Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
sCiEnTiFiC proGrAMME<br />
Sunday 13 May 2012<br />
DEBATE<br />
how iMporTAnT ArE TUMoUr And norMAl TissUE sTEM CElls in rT<br />
lEaRning ObJECTivES:<br />
1. Concept of stem cells in normal tissues and solid tumours<br />
2. Potential implications for radiation oncology<br />
3. Current challenges and future research directions<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 184 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
09:15 - 10:30 • Room 120-121<br />
ChaiR: D. Zips (Germany)<br />
CO-ChaiR: R. Coppes (The Netherlands)<br />
> SPEaKER: A. Klopp (USA) SP-0597<br />
> SPEaKER: R.P. Hill (Canada) SP-0598<br />
> SPEaKER: C. Limoli (USA) SP-0599<br />
> SPEaKER: M. Martin (France) SP-0600<br />
SYMPOSIUM<br />
rTT rEsponsibiliTiEs And inVolVEMEnT in rEsEArCh<br />
lEaRning ObJECTivES:<br />
1. Based on clinical examples, focus will be on RTTs participation in development and<br />
research activities, both as an independent profession and as part of a team<br />
2. The future role for RTTs will be discussed. The importance of specialized RTT’s and<br />
how the role can be developed.<br />
3. To become acquainted with research processes and how research projects can be<br />
developed and implemented<br />
09:15 - 10:30 • Room 118-119<br />
ChaiR: A. Boejen (Denmark)<br />
CO-ChaiR: TBC<br />
09:15 > The role of the imaging specialist RTT<br />
SPEaKER: G. Fagan (Ireland Republic of) SP-0601<br />
09:40 > Strategies for expanding RTT research activity<br />
SPEaKER: J. Cox (Australia) SP-0602<br />
10:05 > How to plan and implement a clinical research RTT project<br />
in the department<br />
SPEaKER: C Meade (Ireland Republic of) SP-0603<br />
Sunday 13 May 2012<br />
abS. numbER<br />
DEBATE<br />
This hoUsE bEliEVEs ThAT ThErE is sTill A rolE For rT<br />
in inTErMEdiATE risK: EndoMETriAl CAnCEr<br />
lEaRning ObJECTivES:<br />
1. To assess the potential therapeutic benefit of RT (EBRT/BT) in regard to loco-regional<br />
control and survival<br />
2. To understand both the risk of RT (EBRT/BT) treatment in regard to RT related<br />
morbidity and QoL as well as the risk of non-RT treatment in regard to cancer<br />
outcome, loco-regional control and survival<br />
3. To understand cost-efficiency issues of both scenarios: treatment and non-treatment<br />
11:00 - 12:00 • Room 112<br />
ChaiR: R. Pötter (Austria)<br />
CO-ChaiR: TBC<br />
11:00 > This house believes that there is still a role for RT in<br />
intermediate risk endometrial cancer - for the motion<br />
SPEaKER: C. Creutzberg (The Netherlands) SP-0604<br />
11:20 > Against the motion<br />
SPEaKER: H. Kitchener (United Kingdom) SP-0605<br />
11:40 > Adjuvant radiation treatment in high-intermediate risk<br />
endometrial cancer patients: for the motion<br />
SPEaKER: C. Haie-Meder (France) SP-0606<br />
12:50 > Conclusions against the motion<br />
SPEaKER: G. Scambia (Italy) SP-0607<br />
SYMPOSIUM<br />
h&n nEw TriAls dEsiGn: rAdioThErApy TEChniQUEs rEQUirEMEnTs<br />
lEaRning ObJECTivES:<br />
1. To select patients who need IMRT<br />
2. To select patients who may benefit from Adaptive Radiotherapy<br />
3. To assess the role of IMRT in patients with Nasopharynx Cancer<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 185<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language